within Pharmacolibrary.Drugs.ATC.V;

model V04CD06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 0.7133333333333333,
    adminDuration  = 600,
    adminMass      = 0.0005,
    adminCount     = 1,
    Vd             = 0.46,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Macimorelin is an orally active ghrelin receptor agonist used as a diagnostic agent for adult growth hormone deficiency (AGHD). It stimulates growth hormone release, facilitating the diagnosis of AGHD. Macimorelin is approved by the FDA for this purpose.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters observed in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Csákváry, V, et al., &amp; Chaychenko, T (2021). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Macimorelin in Children with Suspected Growth Hormone Deficiency: An Open-Label, Group Comparison, Dose-Escalation Trial. <i>Hormone research in paediatrics</i> 94(7-8) 239–250. DOI:<a href=&quot;https://doi.org/10.1159/000519232&quot;>10.1159/000519232</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34438400/&quot;>https://pubmed.ncbi.nlm.nih.gov/34438400</a></p></li><li><p>Piccoli, F, et al., &amp; Drewe, J (2007). Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects. <i>The Journal of clinical endocrinology and metabolism</i> 92(5) 1814–1820. DOI:<a href=&quot;https://doi.org/10.1210/jc.2006-2160&quot;>10.1210/jc.2006-2160</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17284637/&quot;>https://pubmed.ncbi.nlm.nih.gov/17284637</a></p></li><li><p>MacLean, CM, et al., &amp; Beglinger, C (2009). Effect of food on the pharmacokinetics and pharmacodynamics of an oral ghrelin agonist (ARD-07) in healthy subjects. <i>Journal of clinical pharmacology</i> 49(5) 553–559. DOI:<a href=&quot;https://doi.org/10.1177/0091270008330160&quot;>10.1177/0091270008330160</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19293342/&quot;>https://pubmed.ncbi.nlm.nih.gov/19293342</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V04CD06;
